Climb Global Solutions Non-GAAP EPS of $0.43 beats by $0.05, revenue of $220.3M beats by

Climb Global Solutions (CLMB) reported Q3 Non-GAAP EPS of $0.43, exceeding estimates by $0.05. Revenue grew 36.6% year-over-year to $220.3M, surpassing expectations by $39.32M. Adjusted EBITDA rose 35% to $14.7M, and gross billings increased 40% to $706.4M.

Original reporting
Published Oct 29, 2026, 5:37 AM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Oct 29, 2026, 5:45 AM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefEarnings
Primary signal
$CLMB
Bullish
high confidence
Mentioned
$CLMB
Relevance
8/10
AlphAI data visualization · based on seekingalpha.com
Decision brief

The 30-second read

$CLMBBullishHigh
01

Why it matters

The earnings surprise is likely to trigger short-term buying interest, especially in after-hours trading.

02

Market read

First-report earnings beat for a micro-cap tech firm, offering a clear trading catalyst.

03

What to watch

Potential margin pressure from rapid billings growth and upcoming capital expenditures.

Relevance 8/10Novelty 8/10Timing: after-hours release

Background

Climb Global Solutions released its Q3 earnings via a press release, highlighting beats on EPS and revenue.

Company-level read

Ticker impact

$CLMBBullishHigh confidence
Context

Q3 Non-GAAP EPS of $0.43 beats expectations by $0.05 and revenue of $220.3M beats by $39.3M.

Expected impact

likely upward pressure as market prices in the earnings beat

Evidence & confidence

Both EPS and revenue exceeded expectations, indicating better-than-forecast performance.

Market effects

Positive earnings may lift peer companies in the cloud services sector.

Minor impact on US tech equities.

Limited to investors tracking small-cap tech earnings.

Counterpoint

The beat may be modest relative to the high growth rate, and future guidance could be muted.

Key entities

  • Climb Global Solutions

    Provider of cloud-based solutions, ticker CLMB.

Related articles

$CLMBMed

Climb Global (CLMB) Q3 2026 Earnings Call Transcript

Climb Global (CLMB) reported Q3 2026 record results with 40% gross billings growth to $706.4M and 37% net sales growth to $220.3M. Net income rose 69% to $7.9M. The company added Harmonic Security and acquired NeoVAD to expand its portfolio and European presence, focusing on operational efficiency and cloud marketplace development.

$CLMBMed

Climb Global Solutions Reports Record Third Quarter 2026 Results

Climb Global Solutions, Inc. (CLMB) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 Climb Global Solutions Reports Record Third Quarter 2026 Results Financial Metric Q3 2026 Performance vs. Same Year-Ago Quarter Net Sales Up 37% to $220.3 million Gross Billings Up 40% to $706.4 million Net Income Up 69% to $7.9 million Diluted Earnings per Share $0.

$CLMBMedAI 8/10

Climb Bio reports 38% immunologic remission in kidney trial

Climb Bio (NASDAQ: CLYM) reported initial Phase 2 trial results for its kidney-disease treatment, PrisMN, showing 38% immunologic remission in the low-dose cohort and a 70% reduction in disease-linked antibodies. The company plans to release additional data in 2027. Climb shares closed at $10.19 before the announcement. The trial aims to identify a dose for pivotal development, with no serious adverse events reported.